Education
About Us
Working with TipRanks
Follow Us
Rapid Micro Biosystems (RPID)
NASDAQ:RPID
Earnings Data
Report Date
May 02, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.25Last Year’s EPS
-0.31Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 28, 2025
|% Change Since: -22.05%
|Next Earnings Date:May 02, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and strategic partnerships aimed at enhancing future performance. However, challenges such as validation decreases and negative product margins remain. The outlook for 2025 is conservative, reflecting ongoing uncertainties.Company Guidance
During the Rapid Micro Biosystems' fourth quarter 2024 earnings call, the company provided several key metrics and guidance for 2025. They reported a Q4 revenue of $8.2 million, marking a 30% year-over-year increase and a quarterly record. Recurring revenue reached $4.2 million, a 27% growth from the previous year. The company placed six Growth Direct systems in Q4, totaling 21 placements for the full year and bringing the cumulative global placements to 162 systems. Fourth quarter gross margins improved to 12%, up from 8% in Q3 and a 15 percentage point increase from the prior year. For 2025, Rapid Micro anticipates a total revenue of at least $32 million with 21 to 25 system placements, while maintaining a focus on improving gross margins and accelerating system placements. The new distribution and collaboration agreement with MilliporeSigma is expected to expand market reach and enhance supply chain efficiencies, although its revenue impact is not accounted for in the 2025 guidance.Record-Breaking Revenue and Growth
Total revenue for Q4 2024 was $8.2 million, representing a 30% year-over-year growth and a quarterly record. Recurring revenue was $4.2 million, with a growth of 27% compared to the prior year quarter.
Improved Gross Margins
Fourth quarter gross margins improved to 12%, up from 8% in the third quarter, and a 15 percentage point improvement compared to the prior year quarter. Full year 2024 gross margins were effectively breakeven compared to negative 24% for the full year 2023.
Strategic Partnership with MilliporeSigma
Announced a global distribution and collaboration agreement with the Life Science business of Merck KGaA, expected to accelerate system placements and improve gross margins. The agreement includes a commitment from MilliporeSigma to purchase a minimum number of Growth Direct systems over five years.
Operational Efficiency and Cost Reduction
Operational expenses decreased by 7% from Q4 2023 due to an operational efficiency program, with R&D expenses seeing a modest increase due to new product development.
---
RPID Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
RPID Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 28, 2025 | $3.31 | $3.05 | -7.85% |
| Nov 01, 2024 | $1.08 | $1.10 | +1.85% |
| Aug 02, 2024 | $0.68 | $0.80 | +17.65% |
| May 03, 2024 | $0.99 | $0.89 | -10.10% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Rapid Micro Biosystems (RPID) report earnings?
Rapid Micro Biosystems (RPID) is schdueled to report earning on May 02, 2025, TBA Not Confirmed.
What is Rapid Micro Biosystems (RPID) earnings time?
Rapid Micro Biosystems (RPID) earnings time is at May 02, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RPID EPS forecast?
RPID EPS forecast for the fiscal quarter 2025 (Q1) is -0.25.
---